推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

[PDF] Evaluating Smoking Cessation Interventions and Cessation Rates in Cancer Patients: A Systematic Review and Meta-Analysis

[PDF] from hindawi.comS Nayan, MK Gupta… - 2011 - downloads.hindawi.com
... and those who quit prior to treatment [6]. Tobacco smoking also exacerbates and prolongs
radiotherapy induced complications such as mucositis, dry mouth, loss of taste, voice, impaired
pulmonary function, wound healing, as well as tissue and bone necrosis [4, 7 ... reast (21),P ...
Related articles - View as HTML

Overview of Genetic Syndromes Associated with Adrenocortical Cancer

T Else - Adrenocortical Carcinoma, 2011 - Springer
... TP53 17p13 1:20,000 or less common Early age of onset of multiple cancers Typ ica l L F S :
soft tissue sarcomas and o steosarcomas, b reast cancer, brain tumors, leuk emia, and A CC;
Extended L FS: melanoma, prostate cancer, and pancreatic cancer, others ...
Related articles - All 2 versions

The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab

D Castellano, JM Sepulveda, I García-Escobar… - The …, 2011 - AlphaMed Press
... Clinical Studies of Denosumab in Breast Cancer. Breast cancer can induce several
osteotropic factors that in turn induce RANK-L production by stromal cells in bone
marrow. In experimental models, breast cancer cells increase ...
Cited by 2 - Related articles - All 3 versions

Role of MicroRNAs in Anti-cancer Drug Resistance

EAC Wiemer - MicroRNAs in Cancer Translational Research, 2011 - Springer
... cells MicroRN A platform/remarks References Cisplatin B reast cancer; M CF-7; MCF-7/CDDP
miR-10a miR-10b miR-29a miR-29b miR-132 miR-146a miR-194 miR-206 miR-214 miR-221
miR-222 ... Microarray Boren et al. ( 2009 ) Etoposide B reast cancer; M CF-7; MCF-7/VP ...
Related articles - All 2 versions

Bioidentical Hormone Therapy

[HTML] from mayoclinicproceedings.comJA Files, MG Ko… - Mayo Clinic Proceedings, 2011 - mayoclinicproceedings.com
... Estriol, a weak estrogen common to most CBHT formulations, has not been shown to be safe
and effective for the uses for which it is being prescribed (eg, bone loss). ... Claim 5: Compounded
BHT Has a Lower Breast Cancer Risk Than FDA-Approved HT. ...
Related articles - All 5 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451